ClinicalTrials.Veeva

Menu

Effectiveness and Tolerability of Eqwilate in Real-life Conditions

O

Octapharma

Status

Unknown

Conditions

VWD - Von Willebrand's Disease

Treatments

Biological: Eqwilate

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

MOdalities of use, effectiveNEss and TOlerability of Eqwilate® a balanced combInatiON of VWF and FVIII in von WillEbrand patients in real-life conditions: the ONE-TO-ONE study

Enrollment

47 estimated patients

Sex

All

Ages

6+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

The study will involve patients (≥ 6 years of age) from the participating centres treated with Eqwilate® (either on-demand, as perioperative prophylaxis, or as prophylaxis) during the time inclusion period will be opened. Patients will be of any VWD type, previously treated or untreated.

Exclusion criteria

  • N/A

Trial design

47 participants in 1 patient group

Eqwilate
Treatment:
Biological: Eqwilate

Trial contacts and locations

9

Loading...

Central trial contact

Mikaela Raymond

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems